Stay updated with breaking news from Evidence network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
John supports policymakers and stakeholders to harness research evidence, citizen values and stakeholder insights to strengthen health and social systems and get the right programs, services and products to the people who need them. He is Co-Lead of the COVID-19 Evidence Network to support Decision-making (COVID-END) and Rapid-Improvement Support and Exchange (RISE). He is the Director of the McMaster Health Forum, Co-Director of the WHO Collaborating Centre for Evidence-Informed Policy, and Professor in the Department of Health Evidence and Impact at McMaster University, as well as Adjunct Professor at the Africa Centre for Evidence at the University of Johannesburg. He holds an MD from Queen s University, an MSc from the London School of Economics, and a PhD (in Health Policy) from Harvard University. ....
Communication is key to containing COVID miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
08-02-2021 Copyright: Dolyan Basko/Koverznev A. Following an unprecedented year for WHO in 2020, WHO/Europe looks ahead to 2021 with a focus on the continuing COVID-19 pandemic alongside the implementation of the European Programme of Work. With the ongoing roll-out of COVID-19 vaccines and WHO/Europe continuing to provide support in response to the pandemic, this area of work remains a priority. But alongside the pandemic, WHO/Europe offers support and expertise in a many areas to assist countries and partners in delivering health to everyone living in the WHO European Region. This article highlights a select range of important milestones and upcoming events over the course of the year. ....
Population-level screening for cardiovascular disease (CVD) risk factors has no effect on lowering CVD morbidity and mortality, concludes a recently published WHO Health Evidence Network (HEN) report. To reduce CVD risks, which are also associated with poorer COVID-19 outcomes, the report proposes some alternative measures for consideration by policy-makers in the WHO European Region. ....
Reply The study the largest of its kind examined a group of more than 1.1 million patients in the United States and Spain using antihypertensives. (Shutterstock) LOS ANGELES, CA An international research team co-led by a UCLA Fielding School of Public Health professor found that two widely used types of blood pressure drugs are not tied to an increased risk of COVID-19 infection or complications. The study the largest of its kind examined a group of more than 1.1 million patients in the United States and Spain using antihypertensives, according to Dr. Marc Suchard, a professor of biostatistics at the UCLA Fielding School. ....